Primary biliary cirrhosis

被引:302
作者
Talwalkar, JA [1 ]
Lindor, KD [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
D O I
10.1016/S0140-6736(03)13808-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary biliary cirrhosis is a chronic cholestatic liver disease of adults. This disorder is characterised histologically by chronic non-suppurative destruction of interlobular bile ducts leading to advanced fibrosis, cirrhosis, and liver failure. The precise aetiopathogenesis of primary biliary cirrhosis remains unknown, although dysregulation of the immune system and genetic susceptibility both seem to be important. Affected patients are typically middle-aged women with abnormal serum concentrations of alkaline phosphatase. Presence of antimitochondrial antibody in serum is almost diagnostic of the disorder. Identification of primary biliary cirrhosis is important, because effective treatment with ursodeoxycholic acid has been shown to halt disease progression and improve survival without need for liver transplantation. However, therapeutic options for disease-related complications-including fatigue and metabolic bone disease-remain unavailable. Mathematical models have been developed that accurately predict the natural history of primary biliary cirrhosis in individuals. Despite advances in understanding of the disease, it remains one of the major indications for liver transplantation worldwide.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 140 条
  • [1] Abdulkarim AS, 2002, GASTROENTEROLOGY, V122, pA641
  • [2] Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis
    Almasio, PL
    Floreani, A
    Chiaramonte, M
    Provenzano, G
    Battezzati, P
    Crosignani, A
    Podda, M
    Todros, L
    Rosina, F
    Saccoccio, G
    Manenti, F
    Ballardini, G
    Bianchi, FP
    Scheuer, PJ
    Davies, SE
    Craxì, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) : 1645 - 1652
  • [3] Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial
    Angulo, P
    Dickson, ER
    Therneau, TM
    Jorgensen, RA
    Smith, C
    DeSotel, CK
    Lange, SM
    Anderson, ML
    Mahoney, DW
    Lindor, KD
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 830 - 835
  • [4] Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
    Angulo, P
    Jorgensen, RA
    Keach, JC
    Dickson, ER
    Smith, C
    Lindor, KD
    [J]. HEPATOLOGY, 2000, 31 (02) : 318 - 323
  • [5] Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid
    Angulo, P
    Lindor, KD
    Therneau, TM
    Jorgensen, RA
    Malinchoc, M
    Kamath, PS
    Dickson, ER
    [J]. LIVER, 1999, 19 (02): : 115 - 121
  • [6] Angulo P, 1999, Clin Liver Dis, V3, P529, DOI 10.1016/S1089-3261(05)70084-2
  • [7] Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
    Angulo, P
    Patel, T
    Jorgensen, RA
    Therneau, TM
    Lindor, KD
    [J]. HEPATOLOGY, 2000, 32 (05) : 897 - 900
  • [8] VITAMIN-E-DEFICIENCY AND PSYCHOMOTOR DYSFUNCTION IN ADULTS WITH PRIMARY BILIARY-CIRRHOSIS
    ARRIA, AM
    TARTER, RE
    WARTY, V
    VANTHIEL, DH
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 52 (02) : 383 - 390
  • [9] FAMILIAL PRIMARY BILIARY-CIRRHOSIS
    BACH, N
    SCHAFFNER, F
    [J]. JOURNAL OF HEPATOLOGY, 1994, 20 (06) : 698 - 701
  • [10] EFFECT OF URSODEOXYCHOLIC ACID ON SERUM-LIPIDS OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
    BALAN, V
    DICKSON, ER
    JORGENSEN, RA
    LINDOR, KD
    [J]. MAYO CLINIC PROCEEDINGS, 1994, 69 (10) : 923 - 929